ZUG, Switzerland, Sept. 30, 2026 (GLOBE NEWSWIRE) — Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) announced the results of a Scoping Study (the “Scoping Study”) ...
MDS-UPDRS motor scores demonstrated stability to baseline recorded at study entry with no disease progression among the 12 evaluable participants who completed 12 months of daily oral administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results